106 related articles for article (PubMed ID: 33356597)
1. Dietary Patterns and Breast Cancer Risk in Women from Northern Mexico.
Flores-García MK; Mérida-Ortega Á; Denova-Gutiérrez E; López-Carrillo L
Nutr Cancer; 2021; 73(11-12):2763-2773. PubMed ID: 33356597
[TBL] [Abstract][Full Text] [Related]
2. Dietary Glycemic Index and Glycemic Load and Risk of Breast Cancer by Molecular Subtype in Mexican Women.
Guerrero CH; Gamboa-Loira B; Mérida-Ortega Á; López-Carrillo L
Nutr Cancer; 2019; 71(8):1283-1289. PubMed ID: 31058544
[TBL] [Abstract][Full Text] [Related]
3. A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women.
Rojas-Lima E; Gamboa-Loira B; Cebrián ME; Rothenberg SJ; López-Carrillo L
Breast Cancer Res Treat; 2020 Apr; 180(3):791-800. PubMed ID: 32086656
[TBL] [Abstract][Full Text] [Related]
4. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
5. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
7. The impact of selected risk factors among breast cancer molecular subtypes: a case-only study.
Pizzato M; Carioli G; Rosso S; Zanetti R; La Vecchia C
Breast Cancer Res Treat; 2020 Nov; 184(1):213-220. PubMed ID: 32851454
[TBL] [Abstract][Full Text] [Related]
8. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.
Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L
Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186
[TBL] [Abstract][Full Text] [Related]
9. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
10. Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study.
Ferrari P; Rinaldi S; Jenab M; Lukanova A; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Fagherazzi G; Touillaud M; Kaaks R; von Rüsten A; Boeing H; Trichopoulou A; Lagiou P; Benetou V; Grioni S; Panico S; Masala G; Tumino R; Polidoro S; Bakker MF; van Gils CH; Ros MM; Bueno-de-Mesquita HB; Krum-Hansen S; Engeset D; Skeie G; Pilar A; Sánchez MJ; Buckland G; Ardanaz E; Chirlaque D; Rodriguez L; Travis R; Key T; Khaw KT; Wareham NJ; Sund M; Lenner P; Slimani N; Norat T; Aune D; Riboli E; Romieu I
Am J Clin Nutr; 2013 Feb; 97(2):344-53. PubMed ID: 23269820
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
Khabaz MN
Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
[TBL] [Abstract][Full Text] [Related]
13. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
14. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy.
Giuliani S; Leonardi E; Aldovini D; Bernardi D; Pellegrini M; Soli F; Ferro A; Dalla Palma P; Decarli N; Barbareschi M
Pathologica; 2012 Jun; 104(3):93-7. PubMed ID: 22931039
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
17. ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.
Arena V; Pennacchia I; Vecchio FM; Carbone A
Breast J; 2019 May; 25(3):381-385. PubMed ID: 30916428
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.
Xing P; Li J; Jin F
Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy.
Petric M; Martinez S; Acevedo F; Oddo D; Artigas R; Camus M; Sanchez C
Asian Pac J Cancer Prev; 2014; 15(23):10277-80. PubMed ID: 25556461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
